BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 25471802)

  • 1. In vivo handling and metabolism of lipid emulsions.
    Carpentier YA; Deckelbaum RJ
    World Rev Nutr Diet; 2015; 112():57-62. PubMed ID: 25471802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blood clearance and tissue uptake of intravenous lipid emulsions containing long-chain and medium-chain triglycerides and fish oil in a mouse model.
    Treskova E; Carpentier YA; Ramakrishnan R; Al-Haideri M; Seo T; Deckelbaum RJ
    JPEN J Parenter Enteral Nutr; 1999; 23(5):253-7; discussion 258-9. PubMed ID: 10485437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravenous lipid emulsions to deliver omega 3 fatty acids.
    Carpentier YA; Hacquebard M
    Prostaglandins Leukot Essent Fatty Acids; 2006 Sep; 75(3):145-8. PubMed ID: 16872819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blood clearance kinetics and organ delivery of medium-chain triglyceride and fish oil-containing lipid emulsions: Comparing different animal species.
    Hu C; Ding H; Zhuang Q; Llanos P; Pillay T; Hernandez C; Carpentier YA; Deckelbaum RJ; Chang CL
    Clin Nutr; 2021 Mar; 40(3):987-996. PubMed ID: 32753350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo and in vitro properties of an intravenous lipid emulsion containing only medium chain and fish oil triglycerides.
    Ton MN; Chang C; Carpentier YA; Deckelbaum RJ
    Clin Nutr; 2005 Aug; 24(4):492-501. PubMed ID: 16054521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Omega-3 triglycerides modify blood clearance and tissue targeting pathways of lipid emulsions.
    Qi K; Seo T; Al-Haideri M; Worgall TS; Vogel T; Carpentier YA; Deckelbaum RJ
    Biochemistry; 2002 Mar; 41(9):3119-27. PubMed ID: 11863451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Higher docosahexaenoic acid, lower arachidonic acid and reduced lipid tolerance with high doses of a lipid emulsion containing 15% fish oil: a randomized clinical trial.
    D'Ascenzo R; Savini S; Biagetti C; Bellagamba MP; Marchionni P; Pompilio A; Cogo PE; Carnielli VP
    Clin Nutr; 2014 Dec; 33(6):1002-9. PubMed ID: 24525115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of particle size on blood clearance and tissue uptake of lipid emulsions with different triglyceride compositions.
    Qi K; Al-Haideri M; Seo T; Carpentier YA; Deckelbaum RJ
    JPEN J Parenter Enteral Nutr; 2003; 27(1):58-64. PubMed ID: 12549600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Omega-3 fatty acid containing diets decrease plasma triglyceride concentrations in mice by reducing endogenous triglyceride synthesis and enhancing the blood clearance of triglyceride-rich particles.
    Qi K; Fan C; Jiang J; Zhu H; Jiao H; Meng Q; Deckelbaum RJ
    Clin Nutr; 2008 Jun; 27(3):424-30. PubMed ID: 18362042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fatty acids, lipid emulsions and the immune and inflammatory systems.
    Miles EA; Calder PC
    World Rev Nutr Diet; 2015; 112():17-30. PubMed ID: 25471799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid changes in liver lipid composition and pancreatic islet K+ handling and secretory behaviour provoked by the intravenous administration of a medium-chain triglyceride: fish oil emulsion to long-chain polyunsaturated omega3 fatty acid-depleted rats.
    Louchami K; Zhang Y; Oguzhan B; Delporte C; Portois L; Carpentier YA; Genten F; Danguy A; Malaisse WJ; Sener A
    Int J Mol Med; 2006 Dec; 18(6):1047-55. PubMed ID: 17089007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Four-week parenteral nutrition using a third generation lipid emulsion (SMOFlipid)--a double-blind, randomised, multicentre study in adults.
    Klek S; Chambrier C; Singer P; Rubin M; Bowling T; Staun M; Joly F; Rasmussen H; Strauss BJ; Wanten G; Smith R; Abraham A; Szczepanek K; Shaffer J
    Clin Nutr; 2013 Apr; 32(2):224-31. PubMed ID: 22796064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is There an Advantage in Enriching Parenteral Lipid Emulsions Containing Fatty Acids From Fish Oil With Medium-Chain Triglycerides? A Study on Body Pool Concentrations of ω-3 Fatty Acids in Lewis Rats.
    Tesser A; Torrinhas RSMM; Garla PC; Oliveira-Filho RS; Aprobato FGG; Tamanaha EM; Antunes MS; Sampaio GR; Torres E; Calder PC; Linetzky Waitzberg D
    JPEN J Parenter Enteral Nutr; 2021 Sep; 45(7):1581-1590. PubMed ID: 33111317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fish oil-based lipid emulsions prevent and reverse parenteral nutrition-associated liver disease: the Boston experience.
    de Meijer VE; Gura KM; Le HD; Meisel JA; Puder M
    JPEN J Parenter Enteral Nutr; 2009; 33(5):541-7. PubMed ID: 19571170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Particle size determines effects of lipoprotein lipase on the catabolism of n-3 triglyceride-rich particles.
    Xia L; Fan C; Dong H; Wang C; Lu Y; Deckelbaum RJ; Qi K
    Clin Nutr; 2015 Aug; 34(4):767-74. PubMed ID: 25048714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipid injectable emulsions: 2006.
    Driscoll DF
    Nutr Clin Pract; 2006 Aug; 21(4):381-6. PubMed ID: 16870806
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inclusion of 10% fish oil in mixed medium-chain triacylglycerol-long-chain triacylglycerol emulsions increases plasma triacylglycerol clearance and induces rapid eicosapentaenoic acid (20:5n-3) incorporation into blood cell phospholipids.
    Simoens CM; Deckelbaum RJ; Massaut JJ; Carpentier YA
    Am J Clin Nutr; 2008 Aug; 88(2):282-8. PubMed ID: 18689362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent developments in lipid emulsions: relevance to intensive care.
    Carpentier YA; Simoens C; Siderova V; el Nakadi I; Vanweyenberg V; Eggerickx D; Deckelbaum RJ
    Nutrition; 1997 Sep; 13(9 Suppl):73S-78S. PubMed ID: 9290113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new intravenous fat emulsion containing soybean oil, medium-chain triglycerides, olive oil, and fish oil: a single-center, double-blind randomized study on efficacy and safety in pediatric patients receiving home parenteral nutrition.
    Goulet O; Antébi H; Wolf C; Talbotec C; Alcindor LG; Corriol O; Lamor M; Colomb-Jung V
    JPEN J Parenter Enteral Nutr; 2010; 34(5):485-95. PubMed ID: 20852176
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravenous lipids in preterm infants: impact on laboratory and clinical outcomes and long-term consequences.
    Vlaardingerbroek H; van Goudoever JB
    World Rev Nutr Diet; 2015; 112():71-80. PubMed ID: 25471804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.